.png)
- 40% faster test case creation
- $2.4M in annual QA labor savings
- Accelerated time-to-market for new therapies
Business Context
The company’s manual QA process strained under the demands of biopharma’s strict regulatory environment:
- Slow Test Authoring: Manual creation of thousands of test cases delayed releases.
- Compliance Risk: Incomplete coverage jeopardized audit readiness.
- High Labor Costs: QA teams spent disproportionate time on repetitive tasks.
- Limited Collaboration: Misalignment between QA and product slowed feedback loops.
- Innovation Bottleneck: Slow QA cycles delayed drug and therapy rollouts.
Solution
Forte Group developed an AI-powered Test Automation Assistant to streamline QA processes while meeting compliance requirements.
Key components included:
- Automated Test Generation: AI authored test cases from requirements and user stories.
- Coverage Validation: Ensured all regulatory and functional requirements were represented.
- Audit Trails: Complete documentation to satisfy compliance audits.
- Continuous Integration: Integrated seamlessly into existing QA workflows.
- Collaboration Features: Improved alignment between QA, product, and compliance teams.
- Iterative Learning: AI refined outputs based on feedback from QA specialists.
Results & Value Delivered
- 40% faster test case creation across QA teams
- $2.4M in annual labor savings from reduced manual effort
- Improved compliance confidence with complete audit-ready documentation
- Shortened release cycles, accelerating time-to-market for new therapies
- QA staff redeployed to focus on higher-value testing and validation
- Stronger collaboration between QA and product teams, improving product quality
AI-powered automation reduced test authoring time by 40%, saving ~$2.4M annually and accelerating time-to-market while ensuring audit-ready compliance.
